Preliminary Safety and Tolerability of a Novel Subcutaneous Intrathecal Catheter System for Repeated Outpatient Dosing of Nusinersen to Children and Adults With Spinal Muscular Atrophy
Discussion:
Preliminary observations reveal the SIC to be relatively safe and well tolerated in SMA patients with advanced disease and spinal fusion. The SIC warrants further study and, if proven effective in larger trials of longer duration, could double the number of patients able to receive nusinersen worldwide while reducing administration costs 5- to 10-fold.
Source: Journal of Pediatric Orthopaedics - Category: Orthopaedics Tags: Neuromuscular Source Type: research
More News: Back Curves | Brain | Children | National Institutes of Health (NIH) | Neurology | Orthopaedics | Pathology | Pediatrics | Respiratory Medicine | Scoliosis | Spinal Muscular Atrophy | Study | Ultrasound